Evidence map›Paper›PMID 41601968›Full record

ArticleFrontiers in pharmacology2025

Clinical outcomes of adverse drug reaction-related hospital admissions in older adults with diabetes.

Azizah Vonna, Mohammed S Salahudeen, Gregory M Peterson

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Diuretics in Cardiovascular Disease: For How Long and at What Dose?Journal of cardiovascular development and disease · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Azizah VonnaSchool of Pharmacy and Pharmacology, UTAS Health, University of Tasmania, Hobart, TAS, Australia.
Mohammed S SalahudeenSchool of Pharmacy and Pharmacology, UTAS Health, University of Tasmania, Hobart, TAS, Australia.
Gregory M PetersonSchool of Pharmacy and Pharmacology, UTAS Health, University of Tasmania, Hobart, TAS, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This is a retrospective cohort study aimed to investigate the association of adverse drug related (ADR)-related hospital admissions with adverse clinical outcomes, including in-hospital mortality, length of stay (LOS), and hospital readmission among older adults with diabetes. Methods: All individuals aged 65 years and older with diabetes who were admitted to the three major public hospitals in Tasmania, Australia, between July 2017 and December 2023 were identified using International Classification of Diseases codes. Patients with at least one ADR-related hospital admission were propensity score matched with and those without ADR-related admissions based on age, sex, year of index admission, diagnosis-related groups, socioeconomic status, and comorbidities. Adjusted logistic regression was used to assess in-hospital mortality. Length of stay was analysed using a generalised linear model with a Gamma distribution, and readmission risk at 30, 60, and 90 days was assessed using Cox proportional hazards models. Results: After matching, a total of 5,038 older patients with diabetes were included in the in-hospital mortality analysis, and 4,674 were included in the LOS and readmission analyses. Patients with ADR-related hospitalisations had a significantly higher risk of in-hospital mortality (adjusted odds ratio = 1.31; 95% CI: 1.03-1.66; p < 0.05), longer LOS (adjusted ratio = 1.24 (1.13-1.37); p < 0.001, and a greater risk of readmission (the highest adjusted hazard ratio was at 60 days = 1.29 (1.14-1.45); p < 0.001) compared to those without ADR-related hospital admissions. Conclusion: ADR-related hospital admissions were associated with poorer clinical outcomes in older adults with diabetes, including greater mortality, prolonged hospital stays, and increased risk of readmission. These findings underscore the importance of early ADR detection, structured medication review, ongoing monitoring, and patient-centered education to improve medication safety and optimise outcomes in this high-risk group.

Indexed as

adverse drug reactionsclinical outcomesdiabetes mellitusin-hospital mortalitylength of stayolder adultrehospitalisation

Identifiers

PMID41601968
PMCPMC12832289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.